Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

National Research (NRC) Non Operating Income: 2010-2025

Historic Non Operating Income for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to -$1.5 million.

  • National Research's Non Operating Income fell 11418.13% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.4 million, marking a year-over-year decrease of 8662.09%. This contributed to the annual value of -$2.5 million for FY2024, which is 291686.75% down from last year.
  • National Research's Non Operating Income amounted to -$1.5 million in Q3 2025, which was down 11418.13% from -$1.0 million recorded in Q2 2025.
  • National Research's 5-year Non Operating Income high stood at $84000.0 for Q3 2023, and its period low was -$2.8 million during Q4 2022.
  • Over the past 5 years, National Research's median Non Operating Income value was -$432000.0 (recorded in 2022), while the average stood at -$595736.8.
  • As far as peak fluctuations go, National Research's Non Operating Income skyrocketed by 13206.11% in 2023, and later crashed by 394285.71% in 2024.
  • Over the past 5 years, National Research's Non Operating Income (Quarter) stood at -$383000.0 in 2021, then crashed by 623.24% to -$2.8 million in 2022, then skyrocketed by 91.3% to -$241000.0 in 2023, then tumbled by 195.85% to -$713000.0 in 2024, then tumbled by 105.47% to -$1.5 million in 2025.
  • Its Non Operating Income was -$1.5 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$873000.0 in Q1 2025.